M33 Growth I GP LLC
Director, 10% owner at STLN
- Sold, on record
- $28.4M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Sep 4, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STLNStarling Oncology, Inc.Director, 10% owner
Sales by reason
0
Routine
0
Plan not stated
2
No plan
1
Unusual
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 4 sale STLNNo planMay 20, 2025 2025
Sold 2M shares at $2.71 ($5.4M)
M33 Growth I GP LLC, Director, 10% owner
No 10b5-1 planSold 12% of holdings ($45.1M position)14.6M shares leftFirst sale on recordFiling
- 2 Form 4 sale STLNNo planJun 5, 2025 +16 days
Sold 750,000 shares at $3.05 ($2.3M)
M33 Growth I GP LLC, Director, 10% owner
No 10b5-1 planSold 5.1% of holdings ($44.8M position)14M shares leftFiling
- 3 Form 4 sale STLNUnusualSep 4, 2025 +91 days
Sold 6.7M shares at $3.09 ($20.7M)
M33 Growth I GP LLC, Director, 10% owner
No 10b5-1 planSold 45.8% of holdings ($45.2M position)7.9M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Sep 5, 2025 | STLN | Director, 10% owner | Form 4 sale | 6.7M | $20.7M | 45.8% | Unusual | SEC |
| Jun 5, 2025 | Jun 9, 2025 | STLN | Director, 10% owner | Form 4 sale | 750,000 | $2.3M | 5.1% | No plan | SEC |
| May 20, 2025 | May 22, 2025 | STLN | Director, 10% owner | Form 4 sale | 2M | $5.4M | 12.0% | No plan | SEC |